Fibrilación auricular subclínica detectada por dispositivos implantáveis y wearables: revisión sistemática sobre definiciones diagnósticas y anticoagulants
DOI:
https://doi.org/10.5281/zenodo.18312728Palabras clave:
Fibrilación auricular, Anticoagulantes, Dispositivos implantables, Dispositivos portátiles, IctusResumen
La fibrilación auricular subclínica (FA-S), frecuentemente identificada como episodios auriculares de alta frecuencia (EAF) detectados por dispositivos cardíacos implantables y tecnologías portátiles, se asocia con un mayor riesgo de tromboembolia. Sin embargo, la decisión de anticoagular sigue siendo controvertida, ya que el riesgo absoluto de eventos tromboembólicos es variable y el uso de anticoagulantes orales implica un mayor riesgo de hemorragia mayor. Ensayos clínicos aleatorizados recientes demuestran una reducción del ictus y la embolia sistémica a costa de un mayor riesgo hemorrágico, lo que refuerza la necesidad de un tratamiento individualizado.
Referencias
AMERICAN COLLEGE OF CARDIOLOGY; AMERICAN HEART ASSOCIATION; AMERICAN COLLEGE OF CLINICAL PHARMACY; HEART RHYTHM SOCIETY. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, Dallas, v. 149, p. e1–e156, 2 jan. 2024. DOI: 10.1161/CIR.0000000000001193.
EUROPEAN SOCIETY OF CARDIOLOGY; EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, Oxford, v. 45, n. 36, p. 3314–3414, 2024. DOI: 10.1093/eurheartj/ehae176.
GLOTZER, Taya V.; DAOUD, Emile G.; WYSE, D. George et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circulation: Arrhythmia and Electrophysiology, Dallas, v. 2, n. 5, p. 474–480, out. 2009. DOI: 10.1161/CIRCEP.109.849638.
GUO, Yutao; WANG, Hao; ZHANG, Hui et al. Mobile photoplethysmographic technology to detect atrial fibrillation. Journal of the American College of Cardiology, New York, v. 74, n. 19, p. 2365–2375, nov. 2019. DOI: 10.1016/j.jacc.2019.08.019.
HALCOX, Julian P. J.; WAREHAM, Kathie; CARDEW, Antonia et al. Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study. Circulation, Dallas, v. 136, n. 19, p. 1784–1794, 7 nov. 2017. DOI: 10.1161/CIRCULATIONAHA.117.030583.
HEALEY, Jeff S.; CONNOLLY, Stuart J.; GOLD, Michael R. et al. Subclinical atrial fibrillation and the risk of stroke. The New England Journal of Medicine, Boston, v. 366, n. 2, p. 120–129, 12 jan. 2012. DOI: 10.1056/NEJMoa1105575.
HEALEY, Jeff S.; LOPES, Renato D.; GRANGER, Christopher B. et al. Apixaban for stroke prevention in subclinical atrial fibrillation. The New England Journal of Medicine, Boston, v. 390, n. 2, p. 107–117, 11 jan. 2024. DOI: 10.1056/NEJMoa2310234.
KIRCHHOF, Paulus; TOENNIS, Tobias; GOETTE, Andreas et al. Anticoagulation with edoxaban in patients with atrial high-rate episodes. The New England Journal of Medicine, Boston, v. 389, n. 13, p. 1167–1179, 28 set. 2023. DOI: 10.1056/NEJMoa2303062.
LUBITZ, Steven A.; FARANESH, Anthony Z.; SELVAGGI, Caitlin et al. Detection of atrial fibrillation in a large population using wearable devices: the Fitbit Heart Study. Circulation, Dallas, v. 146, n. 19, p. 1415–1424, 8 nov. 2022. DOI: 10.1161/CIRCULATIONAHA.122.060291.
MCINTYRE, William F.; BENZ, Alexander P.; BECHER, Nina et al. Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials. Circulation, Dallas, v. 149, p. 981–988, 26 mar. 2024. DOI: 10.1161/CIRCULATIONAHA.123.067512.
PEREZ, Marco V.; MAHAFFEY, Kenneth W.; HEDLIN, Haley et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. The New England Journal of Medicine, Boston, v. 381, n. 20, p. 1909–1917, 14 nov. 2019. DOI: 10.1056/NEJMoa1901183.
SOCIEDADE BRASILEIRA DE CARDIOLOGIA; SOCIEDADE BRASILEIRA DE ARRITMIA CARDÍACA. Diretriz Brasileira de Fibrilação Atrial – 2025. Arquivos Brasileiros de Cardiologia, São Paulo, v. 122, n. 9, e20250618, 2025. DOI: 10.36660/abc.20250618.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2026 Journal of Social Issues and Health Sciences (JSIHS)
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
